Ahmadi E et al., 2025: Iranian in vitro study showing methylene blue (free or in nano-micelles) plus cold atmospheric plasma reduced U87-MG glioblastoma cell survival, with the micellar form producing more cell death.
Treatment with CAP and MB reduced the survival rate compared to the PS-free group with CAP.
Ahmadi E et al., 2025: Iranian in vitro study showing methylene blue (free or in nano-micelles) plus cold atmospheric plasma reduced U87-MG glioblastoma cell survival, with the micellar form producing more cell death. C3 Ahmadi 2025 (glioblastoma). Study type: in vitro cell-line study (U87-MG) with molecular dynamics simulation. Country: Iran (Mashhad University of Medical Sciences). Dose: 'various concentrations', IC50 determined – values not in the abstract text captured. Light: excitation comes from photons in the cold atmospheric plasma flame, not a lamp/laser. Funder: not stated in the record. Conflicts: 'All authors declare that they have no conflicts of interest or other disclosures.' Comparator: plasma without photosensitiser, free MB vs micelle-MB, untreated cells. The killing agent is a plasma device plus MB, not MB-PDT as usually defined. Study type: lab.
